Prognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based Chemotherapy

PURPOSE: The aim of this study was to verify prognostic factors including sarcopenia in patients with recurrent or metastatic pancreatic cancer receiving gemcitabine-based chemotherapy. MATERIALS AND METHODS: Medical records and computed tomography scan of consecutive patients treated with palliativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Inkeun, Choi, Seung Joon, Kim, Young Saing, Ahn, Hee Kyung, Hong, Junshik, Sym, Sun Jin, Park, Jinny, Cho, Eun Kyung, Lee, Jae Hoon, Shin, Yong Ju, Shin, Dong Bok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080812/
https://www.ncbi.nlm.nih.gov/pubmed/27034148
http://dx.doi.org/10.4143/crt.2015.250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080812/
https://www.ncbi.nlm.nih.gov/pubmed/27034148
http://dx.doi.org/10.4143/crt.2015.250

Ejemplares similares